Moderna's initial vaccine results 'more than hoped for,' says UNC expert
Dr. Cindy Gay, who oversees the clinical trial of Moderna's coronavirus vaccine candidate at UNC-Chapel Hill, says she was the high initial efficacy rate shown by the drug "was more than we were hoping for."
Triangle doctors share different experiences from vaccine trial
Drs. Nirmish and Sandy Shah both participated in the clinical trial for Moderna's potential coronavirus vaccine and had different experiences.
'It means some hope that we are going to beat this thing'
A second experimental COVID-19 vaccine - this one from Moderna Inc. - yielded extraordinarily strong early results Monday, another badly needed dose of hope as the pandemic enters a terrible new phase.
Raleigh man part of Moderna coronavirus vaccine trial
Former N.C. republican Party director Dallas Woodhouse is among the 30,000 participants in the clinical trial for Moderna's potential coronavirus vaccine, which reported initials results Monday of nearly 95 percent efficacy.
2nd virus vaccine shows striking success in US tests
A second experimental COVID-19 vaccine -- this one from Moderna Inc. -- yielded extraordinarily strong early results Monday, another badly needed dose of hope as the pandemic enters a terrible new phase.
PPD lands praise from partner Moderna which reports strong results for COVID-19 vaccine
Moderna says COVID-19 vaccine is proving to be highly effective in a major trial, a second dash of hope in the global race for a shot to tame a resurgent virus that is now killing more than 8,000 people a day worldwide. And the result led to praise for PPD.
'I was eager to participate:' Chapel Hill resident involved in coronavirus vaccine clinical trial
A milestone in the race for a coronavirus vaccine -- Moderna is the first company to get the 30,000 volunteers needed to its vaccine. It's significant because that is the number of participants need to eventually get FDA approval.
Moderna president: Vaccine could be on market by early December
Moderna, the first company to start US clinical trials of a Covid-19 vaccine, on Thursday finished enrolling all 30,000 of its participants.